Arab Finance: Sabaa International for Pharmaceutical and Chemical Industry (SIPC) incurred net losses after tax of EGP 2.422 million during the first half (H1) of 2023, versus net profits after tax amounting to EGP 1.820 million in H1 2022, according to an August 14th disclosure filed to the Egyptian Exchange.
Revenues fell to EGP 5.216 million during the January-June period of this year from EGP 6.10 million during the first six months of 2022.
Sabaa is an Egypt-based company engaged in the pharmaceutical sector. The company’s generic product portfolio includes products focused on different therapeutic categories.